PubMed · 1886076
Complement C5a receptor assay for high throughput screening.
Abstract
The complement C5a receptor on U937 cells, a human histiocytic lymphoma cell line, stimulated with dibutyryl-cAMP have been stabilized for at least 3 months at a dilute, ready to use concentration. [125I]-Bolton Hunter labeled C5a, (recombinant, human) has been prepared by reverse phase HPLC to 2200 Ci/mmol. Using a filtration binding assay the Kd from receptor saturation analysis is 10-40 pM and there are 50,000-100,000 receptor sites per cell. These reagents have permitted the development of a reliable, reproducible and convenient drug screening assay, in kit format, for compounds acting at the C5a receptor.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
S R Harris, R K Garlick, J J Miller, H N Harney, P J Monroe. 1991. Complement C5a receptor assay for high throughput screening.. https://doi.org/10.3109/10799899109066393
Cite the original work for its findings. Save a collection to share your selection of sources.